Deletion of two prostate cancer risk-associated CTCF anchor regions by CRISP-Cas9 resulted in highly elevated expression of genes within the loops, suggesting that disruption of TAD organization could alter gene expression and contribute to prostate tumorigenesis (81). This evidence concerns the gene CTCF and prostate cancer.